Recent scientific findings demonstrate that human antiviral immunity and bacterial anti-phage defense mechanisms share remarkably similar evolutionary origins, structures, and functional strategies across all kingdoms of life. Both human cells and bacteria employ conserved protein pathways, such as cGAS–STING and inflammasomes, alongside nucleotide-based immune signaling molecules to detect and disrupt viral replication. Furthermore, these cellular defense systems utilize comparable mechanisms for pathogen recognition, signal amplification, and targeted effector functions like nucleic acid degradation and membrane disruption. Although human cells prioritize early innate and adaptive responses while bacteria often deploy late-stage cell death as a protective barrier, the overall architectural rules of host-virus interactions remain fundamentally unified.
References:
Kranzusch P J. Shared principles of human and bacterial antiviral immunity[J]. Nature, 2026, 656(8127): 307-319.

